Guided Therapeutics (GTHP) Dividend Yield (2023 - 2024)
Guided Therapeutics' (GTHP) quarterly Dividend Yield came in at 1828.31% in Q1 2024, up 76889.0% year-over-year from N/an in Q2 2023, and up 461.68% quarter-over-quarter from 505.51% in Q2 2023.
Powered by 
Analysis
Guided Therapeutics (GTHP) Dividend Yield (2023 - 2024) Analysis & Trends
Guided Therapeutics has disclosed Dividend Yield across 2 years of filings, most recently posting 1828.31% for Q1 2024.
- In Q1 2024, Dividend Yield rose 76889.0% year-over-year to 1828.31%; the TTM figure through Jun 2024 stood at 1828.31% (up 122625.0% YoY), while the FY2023 annual figure was 1.34%, up 11.0% from the prior year.
- Dividend Yield came in at 1828.31% for Q1 2024 at Guided Therapeutics, up from 505.51% in the prior quarter.
- In the past five years, Dividend Yield ranged from a high of 1828.31% in Q1 2024 to a low of 505.51% in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 1,828.31% |
| Jun 30, 2023 | -505.51% |
| Mar 31, 2023 | 1,059.42% |